Qielan Wu, Shiyu Bai, Miya Su, Yuwei Zhang, Xuran Chen, Ting Yue, Linfeng Xu, Lu Wang, Di Xie, Shuhang Li, Xiang Li, Sicheng Fu, Lili Wang, Chenxi Tian, Jun Pan, Yuanyuan Huang, Yuting Cai, Yu Wang, Fang Hu, Fengyin Li, Huimin Zhang, Li Bai

HIVEP3 inhibits fate decision of CD8+ invariant NKT cells after positive selection

  • Cell Biology
  • Immunology
  • Immunology and Allergy
Save to CiteDrive Show PDF

Abstract CD8+ invariant natural killer T (iNKT) cells are functionally different from other iNKT cells and are enriched in human but not in mouse. To date, their developmental pathway and molecular basis for fate decision remain unclear. Here, we report enrichment of CD8+ iNKT cells in neonatal mice due to their more rapid maturation kinetics than CD8− iNKT cells. Along developmental trajectories, CD8+ and CD8− iNKT cells separate at stage 0, following stage 0 double-positive iNKT cells, and differ in HIVEP3 expression. HIVEP3 is lowly expressed in stage 0 CD8+ iNKT cells and negatively controls their development, whereas it is highly expressed in stage 0 CD8− iNKT cells and positively controls their development. Despite no effect on IFN-γ, HIVEP3 inhibits granzyme B but promotes interleukin-4 production in CD8+ iNKT cells. Together, we reveal that, as a negative regulator for CD8+ iNKT fate decision, low expression of HIVEP3 in stage 0 CD8+ iNKT cells favors their development and T helper 1–biased cytokine responses as well as high cytotoxicity.

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

  • Web-based, modern reference management
  • Collaborate and share with fellow researchers
  • Integration with Overleaf
  • Comprehensive BibTeX/BibLaTeX support
  • Save articles and websites directly from your browser
  • Search for new articles from a database of tens of millions of references
Try out CiteDrive

More from our Archive